Session Four: How Can C-Peptide Be Used to Accelerate Drug Development in New-Onset T1D?
A Talk by Joseph Hedrick (Executive Director, Type 1 Diabetes Consortium, Critical Path Institute)
About this Talk
- Topic Four: C-Peptide Context of Use and Comparative Trial Design (C-Pep vs HbA1c)
- Topic Five: What Levels of C-Peptide Could Support Benefit (Benefit: Risk context)